Spread of infection and treatment interruption among Japanese workers during the COVID-19 pandemic: a cross-sectional study

Introduction

COVID-19, first identified at the end of 2019, is continuing to rage around the world [1–4]. Japan has experienced four waves of the disease through June 2021. In addition to direct effects of severe pneumonia and acute respiratory failure, COVID-19 has also had indirect health effects. COVID-19-related treatment interruption, particularly in patients with chronic diseases, is an emerging issue in several countries [5.6], including Japan [7]. Studies have reported a significant decrease in the number of prescriptions during the pandemic compared to before, and that 40% of patients requiring regular visits have been seen less frequently [8,9].

Treatment interruption can cause serious health care problems in several ways. First, it can worsen the medical condition of patients with chronic diseases that require regular management. Second, fewer opportunities for regular physical examinations may lead to undiagnosed complications and delayed treatment. Further, such medical problems, which could have been avoided by continued treatment, increases medical costs [10]. Studies performed during the COVID-19 pandemic have reported that treatment interruption among patients with chronic diseases is associated with a variety of factors, including fear of becoming infected when seeing the doctor [11,12], scheduling changes by hospitals [13,14], and shortage of medical resources [11]. These factors presumably have differing degrees of impact depending on the level of infection in the region. In addition, patients with unstable socioeconomic status are more likely to discontinue treatment [7,15,16]. Areas with higher prevalence of COVID-19 may be more affected by the loss of job security and other factors that affect individuals with unstable socioeconomic status.

In Japan, the spread of COVID-19 has varied widely by region in terms of the scale of infection and the speed of spread [17.18]. We hypothesize that differences in regional infection rates will affect treatment interruption in each region. The level of infection in a community may directly or indirectly affect fear of visiting medical institutions, anxiety about going out, and financial difficulties, which may cause treatment interruption. For example, the number of people infected with COVID-19 is reported daily by region. Such information will arouse some degree of anxiety and fear in people living in regions with high levels of infection about the safety of the area and the disease. Tokyo, which has recorded the greatest number of infections in Japan, saw a significant drop in prescriptions through May 2020 [8]. Given that pandemics are known to overwhelm medical resources [19], Japan’s lack of capacity to conduct COVID-19 tests in areas with high levels of infection and limited hospital beds has exposed the limits of the country’s medical resources [20].

However, the relationship between regional COVID-19 infection level and treatment interruption remains to be elucidated. Japan provides an ideal opportunity to test our hypotheses due to the country’s large regional variation in COVID-19 infection levels. Therefore, we investigated the relationship between local infection level and treatment interruption in Japan.

Materials and Methods

Results

The participants’ characteristics together with residential area according to the number of people infected for the entire period are summarized in Table 1. We stratified the 9,510 participants in need of regular treatment into four groups according to the regional infection level. Socioeconomic factors including sex, age, marital status, household income, education, and occupation, and self-assessment of health status and anxiety related to COVID-19 infection were similar among the four groups.

The association between the regional infection level and treatment interruption is summarized in Table 2. According to multivariate analysis, the ORs of treatment interruption for the lowest versus highest regional infection level were 1.32 (95% CI: 1.09–1.59; p=0.003) for the overall incidence rate (per 1,000 population), 1.34 (95% CI: 1.10–1.63; p=0.002) for the overall number of people infected, 1.28 (95% CI: 1.06–1.54; p=0.013) for the monthly incidence rate (per 1,000 population), and 1.38 (95% CI: 1.14–1.67; p=0.001) for the number of people infected per month. For each index of infection level, a higher infection level was linked to more workers experiencing treatment interruption for chronic diseases in Japan. The results remained unchanged after adjusting for age and sex.

Discussion

We found that higher regional levels of COVID-19 infection in Japan were correlated with more workers with diseases requiring regular hospital visits and treatment experiencing treatment interruption. To our knowledge, this is the first report to show that community infection levels are associated with treatment interruption.

It is important to emphasize that the association between infection level and treatment interruption remained after adjusting for individual factors such as socioeconomic and health status. These results suggest that apart from individual characteristics, treatment interruptions during the COVID-19 pandemic were also subject to contextual effects related to regional infection levels. For example, while anxiety related to fear of becoming infected during a medical visit is a personal reaction, individuals living in areas with high levels of infection are likely to feel more anxious than those living in areas with low levels of infection. Rescheduling by medical institutions and health care providers is also expected to occur in areas with higher infection levels. Additionally, the COVID-19 pandemic is affecting individuals’ socioeconomic status, which is determined by factors such as employment instability. Higher levels of infection have greater socioeconomic impact, which may be a factor affecting treatment interruption. Our findings are consistent with those of a previous study showing that such individual factors influence treatment interruption [7]. Thus, our study demonstrates that local spread of COVID-19 infection may affect the behavioral characteristics of workers living in the area. These findings suggest that, in addition to an individual patient approach, a population strategy is also needed to prevent the spread of infection and to avoid treatment interruption for manageable diseases.

In this study, both the number of infected people by region and infection rate were associated with treatment interruption. This suggests that it would be informative to report the incidence rate based on the infection status in each region, which reflects the population of that region. However, Japanese news reports tend to emphasize the number of infected people rather than the infection rate by region, the latter of which may contribute to changing the behavior of more people. A previous study reported that Japanese people have greater trust in local information [22], suggesting that reporting the number of infections by region will have a strong influence on individual’s behavioral changes and risk perception.

Increased treatment interruption in areas with high levels of infection may cause further strain on future health care resources. Delaying and avoiding treatment can result in poorer management of chronic diseases, fewer regular checkups, and missed or delayed start of therapy for deteriorating health conditions. It can also lead to increased complications and poor prognosis. These factors in turn can increase future health care needs in the region. The strain on local health care resources due to the COVID-19 pandemic is a serious challenge, and treatment interruption may be an indirect burden on health care resources due to COVID-19. Thus, reducing treatment interruption for manageable diseases may alleviate downstream consequences on the health care system.

The findings of this study indicate that controlling the level of infection in a community has important implications for treatment interruption. With the COVID-19 pandemic expected to continue for some time, sustained control of community-level spread will protect populations from the indirect effects of COVID-19, which include treatment interruption. In addition, strategies are needed to prevent treatment interruption. For example, telemedicine has and will continue to play a major role in the provision of health care during the COVID-19 pandemic [23–26]. Furthermore, educating patients to avoid treatment interruption and widespread use of long-term prescriptions to prevent patients from running out of regular medications will help reduce medical problems caused by treatment interruption.

A major strength of this study was the relatively large sample size, which allowed us to show, for the first time, an association between community infection level and treatment interruption.

However, this study also had several limitations. First, because we conducted a cross-sectional study, causality could not be determined. However, since it is theoretically unlikely that treatment interruption experienced by an individual will increase the COVID-19 infection rate in a region, we think it is likely that high regional infection rates cause treatment interruption. Second, we did not identify workers’ reasons for discontinuing treatment in this study. As discussed above, there are various possible causes of treatment interruption, which may vary by region. Third, we did not inquire about the diseases being treated. Treatment interruption may vary depending on the presence or absence of symptoms and the potential disadvantages of discontinuing treatment for a particular disease.

Conclusion

We found that higher regional infection levels were linked to more workers experiencing treatment interruption during the third wave of COVID-19 infection in Japan. Our findings suggest that in addition to individual factors such as socioeconomic status and health status, high regional infection levels may contribute to behavioral changes in the local population, leading to treatment interruption. Preventing community spread of COVID-19 may thus be useful for avoiding treatment interruption for chronic diseases, an emerging medical problem brought about by COVID-19.

Funding

This study was supported and partly funded by the University of Occupational and Environmental Health, Japan; General Incorporated Foundation (Anshin Zaidan); The Development of Educational Materials on Mental Health Measures for Managers at Small-sized Enterprises; Health, Labour and Welfare Sciences Research Grants; Comprehensive Research for Women’s Healthcare (H30-josei-ippan-002); Research for the Establishment of an Occupational Health System in Times of Disaster (H30-roudou-ippan-007), scholarship donations from Chugai Pharmaceutical Co., Ltd., the Collabo-Health Study Group, and Hitachi Systems, Ltd.

Data statement

Data not available due to ethical restrictions.

Conflict of interest

The authors declare no conflicts of interest associated with this manuscript.